Topical solution is colorless, transparent, foaming with shaking.
Topical solution colorless, transparent, foaming with shaking.
MiramistinÂ® has a wide spectrum of antimicrobial activity, including hospital strains, antibiotic resistant. The drug has a pronounced bactericidal effect against gram-positive (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae and others), gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp. And others), aerobic and anaerobic monobacteria, defined microbial associations, including hospital strains with antibiotic resistance. It has an antifungal effect on the ascomycetes of the genus Aspergillus and the genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata, etc.) and yeast-like fungi (Candida albicans, Candida tropicalis, Candida krusei, Pityrosporum orbiculare (Malassezia furfur, etc.) dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violacent, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis, etc.), as well as other pathogenic fungi, in the form of monocultures and microbial associations, including fungal microflora with resistance to chemotherapeutic drugs. It has an antiviral effect, is active against complex viruses (herpes viruses, human immunodeficiency virus and others). MiramistinÂ® acts on pathogens of sexually transmitted diseases (Chlamydia spp., Treponema spp., Trichomonas vaginalis, Neisseria gonorrhoeae and others). Effectively prevents infection of wounds and burns. It activates the regeneration processes. It stimulates protective reactions at the site of application, by activating the absorbing and digesting functions of phagocytes, and potentiates the activity of the monocyte-macrophage system. It has a pronounced hyperosmolar activity, as a result of which it stops wound and perifocal inflammation, absorbs purulent exudate, contributing to the formation of a dry scab. Does not damage granulation and viable skin cells, does not inhibit edge epithelization. It does not have a local irritant effect and allergenic properties.
Individual intolerance to the drug.
benzyldimethyl [3- (myristoylamino) propyl] ammonium chloride monohydrate 100 mg
Excipients – 1 l.
Dosage and administration
The drug is ready for use.
Packing instructions for packingth sprayer:
Remove the cap from the vial.
Remove the supplied spray nozzle from its protective packaging.
Attach the spray nozzle to the bottle.
Activate spray nozzle by pressing again.
Surgery, Traumatology, Combustiology. For prophylactic and therapeutic purposes, they irrigate the surface of wounds and burns, loosely tampon wounds and fistulous passages, and fix gauze swabs moistened with the drug. The treatment procedure is repeated 2-3 times a day for 3-5 days. A highly effective method of active drainage of wounds and cavities with a daily flow rate of up to 1 liter of the drug.
Obstetrics, gynecology. In order to prevent postpartum infection, it is used in the form of vaginal irrigation before delivery (5-7 days), in childbirth after each vaginal examination and in the postpartum period, 50 ml of the drug in the form of a tampon with an exposure of 2 hours, for 5 days. During the delivery of women by cesarean section, the vagina is treated immediately before the operation, the uterine cavity and the incision are made during the operation, and in the postoperative period, tampons moistened with the drug are introduced into the vagina with an exposure of 2 hours for 7 days. Treatment of inflammatory diseases is carried out by the course for 2 weeks by intravaginal administration of tampons with the drug, as well as by the method of drug electrophoresis.
Venereology. For the prevention of sexually transmitted diseases, the drug is effective if it is used no later than 2 hours after sexual intercourse. Using the urological applicator, enter the contents of the vial into the urethra for 2-3 minutes: for men (2-3 ml), women (1-2 ml) and the vagina (5-10 ml). To process the skin of the inner surfaces of the hips, pubis, genitals. After the procedure, it is recommended not to urinate for 2 hours.
Urology. In the complex treatment of urethritis and urethroprostatitis, 2-3 ml of the drug is injected 1-2 times a day into the urethra, the course is 10 days.
Otorhinolaryngology. With purulent sinusitis – during a puncture, the maxillary sinus is washed with a sufficient amount of the drug. Tonsillitis, pharyngitis and laryngitis are treated with gargling and / or irrigation using a spray nozzle, 3-4 times pressing, 3-4 times a day. The amount of the drug per rinse 10-15 ml.
Dentistry. For stomatitis, gingivitis, periodontitis, it is recommended to rinse the oral cavity with 10-15 ml of the drug, 3-4 times a day.
Local reactions: in some cases, at the place of use, you may experience a slight burning sensation that passes on its own, after 15-20 seconds, and does not require discontinuation of the drug. Allergic reactions.
When used with antibiotics, their antibacterial and antifungal properties have been enhanced.
There is no evidence of an overdose of MiramistinÂ®.
Do not store above 25 ° C. Keep out of the reach of children.
The Expiration of
is 3 years. Do not use the drug after the expiry date.
Conditions of release from drugstores
4 without prescription6565 dprew4 Without a prescription
Solution to the local Application
Vaginitis, Postpartum infections, For skin infections, Prevention of genital infections, Chlamydia, For urethritis